These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 34088965)

  • 1. Sarcopenia is associated with poor prognosis after chemoradiotherapy in patients with stage III non-small-cell lung cancer: a retrospective analysis.
    Katsui K; Ogata T; Sugiyama S; Yoshio K; Kuroda M; Hiraki T; Kiura K; Maeda Y; Toyooka S; Kanazawa S
    Sci Rep; 2021 Jun; 11(1):11882. PubMed ID: 34088965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skeletal Muscle Loss Is an Imaging Biomarker of Outcome after Definitive Chemoradiotherapy for Locally Advanced Cervical Cancer.
    Lee J; Chang CL; Lin JB; Wu MH; Sun FJ; Jan YT; Hsu SM; Chen YJ
    Clin Cancer Res; 2018 Oct; 24(20):5028-5036. PubMed ID: 29959140
    [No Abstract]   [Full Text] [Related]  

  • 3. Weighing the role of skeletal muscle mass and muscle density in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: a multicenter real-life study.
    Cortellini A; Bozzetti F; Palumbo P; Brocco D; Di Marino P; Tinari N; De Tursi M; Agostinelli V; Patruno L; Valdesi C; Mereu M; Verna L; Lanfiuti Baldi P; Venditti O; Cannita K; Masciocchi C; Barile A; McQuade JL; Ficorella C; Porzio G
    Sci Rep; 2020 Jan; 10(1):1456. PubMed ID: 31996766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-institution study of correlations between skeletal muscle mass, its density, and clinical outcomes in non-small cell lung cancer patients treated with first-line chemotherapy.
    Cortellini A; Palumbo P; Porzio G; Verna L; Giordano AV; Masciocchi C; Parisi A; Cannita K; Ficorella C; Bozzetti F
    Thorac Cancer; 2018 Dec; 9(12):1623-1630. PubMed ID: 30259689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skeletal muscle radiodensity is prognostic for survival in patients with advanced non-small cell lung cancer.
    Sjøblom B; Grønberg BH; Wentzel-Larsen T; Baracos VE; Hjermstad MJ; Aass N; Bremnes RM; Fløtten Ø; Bye A; Jordhøy M
    Clin Nutr; 2016 Dec; 35(6):1386-1393. PubMed ID: 27102408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low skeletal muscle mass predicts poor prognosis for patients with stage III cervical cancer on concurrent chemoradiotherapy.
    Aichi M; Hasegawa S; Kurita Y; Shinoda S; Kato S; Mizushima T; Yokota NR; Miyagi E
    Nutrition; 2023 May; 109():111966. PubMed ID: 36731243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased adipose tissue is associated with improved overall survival, independent of skeletal muscle mass in non-small cell lung cancer.
    Tao J; Fang J; Chen L; Liang C; Chen B; Wang Z; Wu Y; Zhang J
    J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2591-2601. PubMed ID: 37724690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psoas muscle mass in patients undergoing lung cancer surgery: a prognostic difference between squamous cell carcinoma and adenocarcinoma.
    Ozeki N; Kawaguchi K; Fukui T; Nakamura S; Hakiri S; Mori S; Goto M; Iwano S; Yokoi K; Chen-Yoshikawa TF
    Int J Clin Oncol; 2020 May; 25(5):876-884. PubMed ID: 31955305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of Sarcopenia and Metabolic PET-CT Parameters on Survival in Locally Advanced Non-Small Cell Lung Carcinoma.
    Karaman E; Hursoy N; Goksel S
    Nutr Cancer; 2023; 75(1):286-295. PubMed ID: 35959787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sarcopenia Is an Independent Prognostic Factor for Squamous Cell Carcinoma of the Cervix Treated With Concurrent Chemoradiotherapy.
    Kise S; Arakaki Y; Kudaka W; Ariga T; Kinjo N; Kohatu H; Aoki Y
    Anticancer Res; 2022 Oct; 42(10):4887-4893. PubMed ID: 36191992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different computed tomography parameters for defining myosteatosis in patients with advanced non-small cell lung cancer.
    Zhang W; Tang J; Tang H; Xie L; Wang J; Wu J; Yang M
    Clin Nutr; 2023 Dec; 42(12):2414-2421. PubMed ID: 37871482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of computed tomography texture features in non-small cell lung cancers treated with definitive concomitant chemoradiotherapy.
    Ahn SY; Park CM; Park SJ; Kim HJ; Song C; Lee SM; McAdams HP; Goo JM
    Invest Radiol; 2015 Oct; 50(10):719-25. PubMed ID: 26020832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing evaluation of sarcopenia in patients with non-small cell lung cancer (NSCLC) by assessing skeletal muscle index (SMI) at the first lumbar (L1) level on routine chest computed tomography (CT).
    Recio-Boiles A; Galeas JN; Goldwasser B; Sanchez K; Man LMW; Gentzler RD; Gildersleeve J; Hollen PJ; Gralla RJ
    Support Care Cancer; 2018 Jul; 26(7):2353-2359. PubMed ID: 29417293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sarcopenia Is Not a Prognostic Factor of Outcome in Patients With Cervical Cancer Undergoing Concurrent Chemoradiotherapy or Radiotherapy.
    Matsuoka H; Nakamura K; Matsubara Y; Ida N; Nishida T; Ogawa C; Katsi K; Kanazawa S; Masuyama H
    Anticancer Res; 2019 Feb; 39(2):933-939. PubMed ID: 30711978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies.
    Kobayashi T; Kawai H; Nakano O; Abe S; Kamimura H; Sakamaki A; Kamimura K; Tsuchiya A; Takamura M; Yamagiwa S; Terai S
    BMC Cancer; 2018 Jul; 18(1):756. PubMed ID: 30041616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of chemoradiotherapy versus single modality therapy and overall survival among patients with unresectable, stage III non-small cell lung cancer.
    Bobbili P; Ryan K; DerSarkissian M; Dua A; Yee C; Duh MS; Gomez JE
    PLoS One; 2020; 15(3):e0230444. PubMed ID: 32187231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radical radiotherapy or chemoradiotherapy for inoperable, locally advanced, non-small cell lung cancer: Analysis of patient profile, treatment approaches, and outcomes for 213 patients at a tertiary cancer center.
    Shrimali RK; Nallathambi C; Saha A; Das A; Prasath S; Mahata A; Arun B; Mallick I; Achari R; Dabkara D; Thambudorai R; Chatterjee S
    Indian J Cancer; 2018; 55(2):125-133. PubMed ID: 30604722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative skeletal muscle index and visceral-to-subcutaneous fat area ratio are associated with long-term outcomes of elderly gastric cancer patients after gastrectomy.
    Taki Y; Sato S; Nakatani E; Higashizono K; Nagai E; Nishida M; Watanabe M; Ohata K; Kanemoto H; Oba N
    Langenbecks Arch Surg; 2021 Mar; 406(2):463-471. PubMed ID: 33515316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma.
    Fujiwara N; Nakagawa H; Kudo Y; Tateishi R; Taguri M; Watadani T; Nakagomi R; Kondo M; Nakatsuka T; Minami T; Sato M; Uchino K; Enooku K; Kondo Y; Asaoka Y; Tanaka Y; Ohtomo K; Shiina S; Koike K
    J Hepatol; 2015 Jul; 63(1):131-40. PubMed ID: 25724366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of preoperative evaluation of skeletal muscle index and immune-nutritional status for patients with early-stage non-small cell lung cancer.
    Sato S; Sato M; Shinohara H
    Gen Thorac Cardiovasc Surg; 2023 Jun; 71(6):354-362. PubMed ID: 36562876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.